<DOC>
	<DOCNO>NCT00565175</DOCNO>
	<brief_summary>The purpose study investigate whether blockade histamine H2 receptor brain beneficial effect symptom subject schizophrenia .</brief_summary>
	<brief_title>Histamine H2 Antagonism Adjuvant Therapy Treatment Resistant Schizophrenia</brief_title>
	<detailed_description>Histamine function neurotransmitter brain . It important role modulator release neurotransmitter , include dopamine . The histamine receptor widely express brain , H1 H2 receptor post-synaptic , H3 pre-synaptic autoreceptor . There abundance neurobiologic data animal human study support role histamine pathogenesis treatment psychosis . In 1990 case report treatment resistant subject schizophrenia who symptom improve markedly prescribed H2 antagonist peptic ulcer . Later , open-label trial include 18 patient perform , report significant symptom reduction , especially negative symptom . Also subjective comment subject investigator study optimistic suggest effect primarily negative symptom . The present study first double-blind , randomize , placebo control , parallel group study subject matter . The study focus treatment resistant schizophrenia case stable phase .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Histamine</mesh_term>
	<mesh_term>Histamine phosphate</mesh_term>
	<mesh_term>Famotidine</mesh_term>
	<criteria>Diagnosis schizophrenia assess SCIDI ( DSMIV ) well RDCcriteria Patient record mention schizophrenia ( ICD10 ) least 5 year previously Disability pension due psychiatric disorder At least 3 point CGI scale Epilepsy history unclear seizure Stroke Parkinson 's disease AIDS Substance addiction abuse within 3 month prior enrolment . Individuals deem risk aggressive behavior suicide clinician Pregnant breastfeeding subject Serious unstable physical illness Persons deem legally incapacitate accord Finnish law ( Laki holhoustoimesta 1.4.1999/442 , 3. luku , 18 § ) Individuals use H2antagonists prescribed physician Known allergy famotidine component Pepcidin® 40 mg tablet Glomerular Filtration Rate ( GFR ) accord CockcroftGault formula &lt; 30 ml/min</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Treatment resistant</keyword>
	<keyword>Chronic</keyword>
</DOC>